Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  LHC Group, Inc.    LHCG

LHC GROUP, INC. (LHCG)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 05/18 10:00:00 pm
75.34 USD   +0.32%
05/17LHC : to Present at UBS Global Healthcare Conference
BU
05/10LHC : to Present at Bank of America Merrill Lynch 2018 Health Care C..
BU
05/03LHC : 1Q Earnings Snapshot
AQ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

LHC Group, Inc. : LHC Group Earns Recognition From National Publications

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/12/2011 | 09:58pm CEST

LAFAYETTE, La., Dec. 12, 2011 (GLOBE NEWSWIRE) -- LHC Group Inc. (Nasdaq:LHCG), a national provider of home health and hospice services, has been honored as one of the nation's most successful companies by two national publications.

For the fifth consecutive year, LHC Group has been named one of "America's 100 Best Small Companies" by Forbes magazine. In addition, LHC Group has been recognized as one of the nation's "100 Fastest-Growing Companies" by Fortune magazine for the second consecutive year.

Keith G. Myers, chairman and CEO, said the national recognition is a tribute to the skill and compassion of the company's 8,000 employees at more than 300 locations in 19 states.

"At LHC Group, everything we do is centered on one principle: It's all about helping people," Myers said. "We've grown from a single home health agency in rural Louisiana into a national healthcare provider serving 80,000 patients every year, because we've never forgotten a simple fact - we're here to provide high-quality, compassionate health care to the men and women who put their trust in us."

Earlier this year, LHC Group also earned national recognition for its quality of care. Nearly 40 percent of the company's home health providers are rated among the nation's 2011 "HomeCare Elite," an independent ranking of home health quality and performance. The 2011 HomeCare Elite list, compiled annually by OCS HomeCare and DecisionHealth, names the top 25 percent of home health agencies in the United States.

LHC Group is also the only home health company in the country pursuing 100 percent Joint Commission accreditation. Established in 1988, The Joint Commission's home care accreditation program addresses a home care organization's performance in specific areas to help ensure patient care and services are provided in a safe manner.

About LHC Group Inc.

is a national provider of home health and hospice services, providing quality, cost-effective health care to patients within the comfort and privacy of their home or place of residence.  LHC Group provides a comprehensive array of post-acute healthcare services through home health, hospice and private duty locations in its home-based division and long-term acute care hospitals in its facility-based division.

Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements about the company's future financial performance and the strength of the company's operations. Such forward-looking statements may be identified by words such as "continue," "expect" and similar expressions. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including changes in reimbursement, changes in government regulations, changes in LHC Group's relationships with referral sources, increased competition for LHC Group's services, increased competition for joint venture and acquisition candidates, changes in the interpretation of government regulations and other risks set forth in Item 1A.  Risk Factors in LHC Group's Annual Report on Form 10-K for the year ended December 31, 2010, filed with the Securities and Exchange Commission. LHC Group undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: Amy Stevens

         (337) 233-1307
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LHC GROUP, INC.
05/17LHC : to Present at UBS Global Healthcare Conference
BU
05/15LHC : Legislation, Donation Aimed at Decreasing Chances of Potent Opioid Misuse
AQ
05/10LHC : to Present at Bank of America Merrill Lynch 2018 Health Care Conference
BU
05/03LHC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF..
AQ
05/03LHC GROUP, INC : Results of Operations and Financial Condition, Financial Statem..
AQ
05/03LHC : 1Q Earnings Snapshot
AQ
05/02LHC : Announces First Quarter 2018 Financial Results
BU
05/02LHC : and St. Mary’s Health Network announce closure of in-home healthcare..
PU
04/19LHC Group Announces First Quarter 2018 Earnings Release and Conference Call D..
GL
04/12LHC : Announces Successful Completion and Effectiveness of Merger with Almost Fa..
AQ
More news
News from SeekingAlpha
05/06LHC Group's (LHCG) CEO Keith Myers on Q1 2018 Results - Earnings Call Transcr.. 
05/02LHC Group beats by $0.02, beats on revenue 
05/01Notable earnings after Wednesday?s close 
04/03LHC Group up 7% on new Medicare policy expanding coverage for non-skilled hom.. 
04/03CMS finalizes policies to reduce drug costs for Medicare beneficiaries 
Financials ($)
Sales 2018 1 844 M
EBIT 2018 163 M
Net income 2018 93,6 M
Debt 2018 -
Yield 2018 -
P/E ratio 2018 23,52
P/E ratio 2019 18,44
Capi. / Sales 2018 1,34x
Capi. / Sales 2019 1,13x
Capitalization 2 466 M
Chart LHC GROUP, INC.
Duration : Period :
LHC Group, Inc. Technical Analysis Chart | LHCG | US50187A1079 | 4-Traders
Technical analysis trends LHC GROUP, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Average target price 81,7 $
Spread / Average Target 8,4%
EPS Revisions
Managers
NameTitle
Keith G. Myers Chairman & Chief Executive Officer
Donald Dwayne Stelly President & Chief Operating Officer
Joshua L. Proffitt Chief Financial Officer, Treasurer & Executive VP
Angie M. Begnaud Chief Clinical Officer & Executive Vice President
John M. Thompson Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
LHC GROUP, INC.23.00%2 466
FRESENIUS6.25%45 171
HCA HOLDINGS (HOSPITAL CORPORATION AMERICA)17.07%36 314
FRESENIUS MEDICAL CARE-1.41%32 133
LABORATORY CORPORATION OF AMERICA HOLDINGS10.23%18 035
QUEST DIAGNOSTICS3.36%13 814